tiprankstipranks
Advertisement
Advertisement

HK:6996 Stock Latest News

Antengene Grants 1.9 Million Share Options and RSUs to Reward Key Talent
Company AnnouncementsAntengene Grants 1.9 Million Share Options and RSUs to Reward Key Talent
8d ago
Antengene Executives Boost Stakes in Vote of Confidence on Long-Term Growth
PremiumCompany Announcements
Antengene Executives Boost Stakes in Vote of Confidence on Long-Term Growth
21d ago
Antengene Narrows Losses on Cost Cuts as Revenue Climbs in 2025
PremiumCompany Announcements
Antengene Narrows Losses on Cost Cuts as Revenue Climbs in 2025
26d ago
Antengene Schedules Board Meeting to Approve 2025 Annual Results
PremiumCompany Announcements
Antengene Schedules Board Meeting to Approve 2025 Annual Results
1M ago
Antengene Grants UCB Global Rights to ATG-201 in Autoimmune Disease Deal Worth Up to USD1.2 Billion
PremiumCompany Announcements
Antengene Grants UCB Global Rights to ATG-201 in Autoimmune Disease Deal Worth Up to USD1.2 Billion
1M ago
Antengene’s XPOVIO® Gains New Approval in Malaysia for Lymphoma Treatment
PremiumCompany AnnouncementsAntengene’s XPOVIO® Gains New Approval in Malaysia for Lymphoma Treatment
4M ago
Antengene Corporation Enhances Governance with New Committee
Premium
Company Announcements
Antengene Corporation Enhances Governance with New Committee
4M ago
Antengene’s XPOVIO® Gains New Approvals in Hong Kong
Premium
Company Announcements
Antengene’s XPOVIO® Gains New Approvals in Hong Kong
4M ago
Antengene Secures IND Approval for ATG-022 Study in China
PremiumCompany Announcements
Antengene Secures IND Approval for ATG-022 Study in China
4M ago
Antengene Announces Share Repurchase Plan to Boost Shareholder Value
PremiumCompany Announcements
Antengene Announces Share Repurchase Plan to Boost Shareholder Value
8M ago
Antengene Reports Reduced Losses Despite Revenue Dip in H1 2025
PremiumCompany Announcements
Antengene Reports Reduced Losses Despite Revenue Dip in H1 2025
8M ago
Antengene’s ATG-022 Receives Breakthrough Therapy Designation
PremiumCompany Announcements
Antengene’s ATG-022 Receives Breakthrough Therapy Designation
8M ago
Antengene Schedules Board Meeting to Review Interim Results
PremiumCompany AnnouncementsAntengene Schedules Board Meeting to Review Interim Results
8M ago
Antengene’s XPOVIO® Gains Approval in China for Multiple Myeloma Treatment
Premium
Company Announcements
Antengene’s XPOVIO® Gains Approval in China for Multiple Myeloma Treatment
9M ago
Antengene Corporation Announces Change of Hong Kong Business Address
Premium
Company Announcements
Antengene Corporation Announces Change of Hong Kong Business Address
9M ago
Antengene Corporation Successfully Passes All Resolutions at AGM
PremiumCompany Announcements
Antengene Corporation Successfully Passes All Resolutions at AGM
10M ago
Antengene Corporation Announces 2025 AGM with Key Resolutions
PremiumCompany Announcements
Antengene Corporation Announces 2025 AGM with Key Resolutions
12M ago
Antengene Announces Share Repurchase Plan to Boost Shareholder Value
PremiumCompany Announcements
Antengene Announces Share Repurchase Plan to Boost Shareholder Value
1y ago
Antengene Reports Revenue Growth and Reduced Losses for 2024
PremiumCompany Announcements
Antengene Reports Revenue Growth and Reduced Losses for 2024
1y ago
Antengene Corporation to Review Annual Financial Results
PremiumCompany AnnouncementsAntengene Corporation to Review Annual Financial Results
1y ago
Antengene’s XPOVIO® Gains Approval in Indonesia for Multiple Indications
Premium
Company Announcements
Antengene’s XPOVIO® Gains Approval in Indonesia for Multiple Indications
1y ago
Antengene Expands AI Investment to Boost T-Cell Engager Development
Premium
Company Announcements
Antengene Expands AI Investment to Boost T-Cell Engager Development
1y ago

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >